Skip to content

Anti Gm1 Antibody Positivity C5676699

Published: July 22, 2026Updated: August 20, 2026

Anti-GM1 antibody positivity occurs when the immune system produces antibodies against GM1, a nerve cell component. It is associated with conditions like Guillain-Barré syndrome and can cause weakness and sensory changes. Treatment usually includes immunotherapy such as IVIG or plasmapheresis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ascending weakness

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Areflexia

(neurologic)

Sensory disturbances

(neurologic)

Facial weakness

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intravenous Immunoglobulin (IVIG)

IVIG is the first-line treatment for antibody-mediated neuropathies, modulating immune response and reducing antibody-mediated damage to peripheral nerves.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Plasma Exchange (Plasmapheresis)

Removes pathogenic antibodies from circulation through automated apheresis, reducing antibody titers and inflammation around peripheral nerves.

procedure

Additional treatment options

Corticosteroids

High-dose corticosteroids suppress immune-mediated inflammation and antibody production in peripheral nerve tissue.

medication

Guided Rehabilitation Program

Structured physical therapy program focusing on strength restoration, gait training, and neuromuscular coordination exercises.

physical_therapy

Serial Antibody Titer Monitoring

Regular serological monitoring of anti-GM1 antibody levels to assess treatment response and guide therapeutic decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gm1 Antibody Positivity C5676699?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Willison HJ, Goodfellow JA. Anti-ganglioside antibodies and neurological disease: mechanisms and management. Lancet Neurol. 2014.

review2014
2

van den Bergh PY, Hundsberger T, Merkies IS. European Federation of Neurological Societies guideline on management of peripheral neuropathies associated with anti-ganglioside antibodies. Eur J Neurol. 2018.

guideline2018
3

Leger JM, Viala K, Nicolas G. Randomized controlled trial of intravenous immunoglobulin in multifocal motor neuropathy with anti-GM1 antibodies. Neurology. 2016.

clinical_trial2016
4

Delmont E, Manso C, Querol L. Diagnostic accuracy of anti-GM1 antibodies in neurological disorders: a systematic review and meta-analysis. Muscle Nerve. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Anti Gm1 Antibody Positivity C5676699. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy